HOME / Technology Platforms / Antibody Discovery Solution
Technology Platforms

Antibody Discovery Solution

Harbour Mice®

Single Cell Technology Platform

Bispecific Antibodies

Back to list

Antibody Discovery Solution


Leveraging the advantages of Harbour Mice® platforms, Single B Cell technology, and experienced therapeutic antibody discovery team, Harbour provides integrated antibody discovery services from antigen preparation, animal immunization, Single B cell screening, to antibody lead generation through engineering, developability assessment and pharmacological evaluation. Featured by a 3,000m2 fully equipped lab space, state-of-the-art single B cell screening workflow, and display technologies, our discovery team is committed to facilitate drug developers to develop the next-generation therapeutic molecules.


Email Us at:
For Partnership Enquires:
page top

Harbour BioMed has established a robust pipeline in oncology and immunology since the company was established in 2016. The current portfolio includes five clinical-stage in-licensed compounds and a rapidly emerging set of therapeutics coming from its internal discovery efforts as well as co-discovery/development collaborations with academic institutions and biopharmaceutical companies.

contact us